HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.

NCT07233070 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: HRS-7450 Injection
DRUG: HRS-7450 Injection
DRUG: HRS-7450 Injection
DRUG: HRS-7450 Injection Placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.